Various methods and apparatus for a wearable or insertable device (100, 200, 400, 600) with microneedles (106, 206, 306, 406, 606) that may be simultaneously used for radio frequency (RF) energy harvesting, communication, and transdermal fluid delivery and collection are disclosed. Such a device may comprise a substrate (102, 202, 302, 402, 602) that may be affixable/insertable into tissue (107, 607) of a patient, radio frequency circuitry (120, 220, 420, 620) disposed on the substrate, that may generate/process a signal with a frequency that may be modulated to carry information, and microneedles (106, 206, 306, 406, 606) extending from at least one surface of the substrate, where one or more microneedles define a micro-fluidic channel (130, 230, 430, 630) that fluidly couples the tissue with a conduit (132) of the substrate, and where one or more microneedles may be electrically coupled with the radio frequency circuitry and radiate/process electromagnetic waves based on the signal.

Methods and systems for collecting and analyzing blood are provided. The methods and systems generally operate by collecting a blood sample on a portion of a lancet and subjecting the blood sample to optical spectroscopy.

The invention relates to an ingestible, implantable or wearable medical device comprising a microarray which comprises a bioactive agent capable of interacting with a disease marker biological analyte; a reservoir which comprises at least one therapeutic agent and is capable of releasing the therapeutic agent(s) from the medical device; and a plurality of microchips comprising a microarray scanning device capable of obtaining physical parameter data of an interaction between the disease marker biological analyte with the bioactive agent; a biometric recognition device capable of comparing the physical parameter data with an analyte interaction profile; optionally a therapeutic agent releasing device capable of controlling release of the therapeutic agent from the reservoirs; an interface device capable of facilitating communications between the microarray scanning device, biometric recognition device and the therapeutic agent releasing device; and an energy source to power the medical device. Specifically, the invention relates to a medical device capable of detecting an analyte in a bodily fluid comprising at least one microneedle capable of obtaining a sample of a bodily fluid, a first microchannel through which the sample flows and is in fluid communication with the at least one microneedle, a second microchannel in fluid communication with the first microchannel, through which a buffer flows, wherein the second channel comprises a microarray with a bioactive agent, a microarray scanning device to detect an interaction between the bioactive agent and the analyte in the bodily fluid; and an interface device.

In a housing configured to mount thereon a biosensor in an attachable and detachable manner in which the biosensor is configured to have a liquid sample of a biological object deposited thereon, the medial measuring device includes a measuring component operable to measure biological information from the liquid sample of the biological object, a recording component operable to store a result measured by the measuring component, and an information protection component operable to determine an access limitation to personal information data stored in the recording component. With this configuration of the device, it is possible to properly protect personal information stored in the device.

A blood sample collector can be used to collect a blood sample from a subject. The blood sample collector can be placed in a receptacle of a spectrometer to measure spectral data from the blood sample while the blood sample separates. The container may comprise a window to allow light such as infrared light to pass through the container, with the blood sample at least partially separating within the container between spectral measurements, which can provide improved accuracy of the measurements and additional information regarding the sample. The container may comprise an elongate axis and the container configured for placement in the spectrometer receptacle with the elongate axis extending toward a vertical direction in order to improve gravimetric separation of the blood sample. The spectrometer can be configured to measure the blood sample at a plurality of heights along the sample as the sample separates.

A dermal patch for collecting a physiological sample includes a housing with a collection chamber, a sample channel and a pin within a receptacle of the housing. The sample channel is configured to direct a physiological sample drawn from a subject to the collection chamber. The pin is removably positioned within the receptacle and is configured to move from an undeployed position to a deployed position. The pin is configured to seal the receptacle when in the undeployed position and is further configured to facilitate generation of negative pressure in the sample channel when the pin is moved from the undeployed to the deployed position.

A blood glucose detection device includes a carrier body, a flow-guiding actuator, a microneedle patch, a sensor and a controlling chip. The carrier body has a liquid guiding channel, a compressing chamber and a liquid storage chamber. The flow-guiding actuator seals the compressing chamber. The microneedle patch is attached on the carrier body and has plural hollow microneedles. The sensor is disposed within the liquid storage chamber. The controlling chip is disposed on the carrier body. The plural hollow microneedles puncture the skin of a human subject with minimal invasion. The controlling chip controls the flow-guiding actuator to actuate and the tissue fluid is sucked into the liquid storage chamber through the plural hollow microneedles, whereby the sensor detects the blood glucose of the tissue fluid to generate and transmit the measured data to the controlling chip. The controlling chip can generate monitoring information by calculating the measured data.

A system for confirmation of fluid delivery to a patient at the clinical point of use is provided. The system includes a wearable electronic device. The wearable electronic device has a housing; at least one imaging sensor associated with the housing; a data transmission interface; a data reporting accessory for providing data to the user; a microprocessor for managing the at least one imaging sensor, the data transmission interface, and the data reporting accessory; and a program for acquiring and processing images from the at least one imaging sensor. The system further includes a fluid delivery apparatus; and one or more identification tags attached to or integrally formed with the fluid delivery apparatus. The program processes an image captured by the at least one imaging sensor to identify the one or more identification tags and acquires fluid delivery apparatus information from the one or more identification tags.

Systems, methods, techniques, articles, garments and apparatuses for obtaining bodily information from menstrual fluid. A patch portion with a biosensor is placed within the garment or article in communication with the menstrual blood flow. The measured bodily information obtained from the menstruating woman is then transmitted either physically or electronically to a lab or others for further analysis.

A wearable device comprising a display dial configured to display various health parameters, a wristband assisting the device to wear on wrist, an eject-able tray comprising a micro-chip, a first spring coupled to the eject-able tray, at least one latch provided with a second spring to hold the eject-able tray within the device by compressing the first spring, and a health monitoring unit provided with multiple sensors to determine various health parameters, wherein compression of the second spring results in the latch to release the eject-able tray which in turn relaxes the compressed first spring to eject the micro-chip outside the device for collecting blood samples. The microchip comprises at least one micro-needle and an enzyme test strip for collecting and analyzing the blood samples. The health monitoring unit comprises at least three conductive sense pads which are collectively operable to provide electrocardiograph (ECG) information.